Sign In
Buy BWAY
$14.04
-0.520 (-3.57%)
At Close: Jun 03, 2026
BrainsWay's Competitive Advantage Is Growing
11:04am, Friday, 21'st Jan 2022
BrainsWay has clearance for an expanding number of indications, which is supportive of continued growth. There is also growing evidence of the cost-effectiveness of TMS, which should lead to wider ins
Brainsway Stock (BWAY): Why The Price Increased Today
10:20pm, Thursday, 09'th Dec 2021
The stock price of Brainsway (NASDAQ: BWAY) increased by 4.71% today. This is why it happened.
BrainsWay Ltd. (BWAY) CEO Christopher von Jako on Q3 2021 Results - Earnings Call Transcript
12:41pm, Wednesday, 17'th Nov 2021
BrainsWay Ltd. (BWAY) CEO Christopher von Jako on Q3 2021 Results - Earnings Call Transcript
BrainsWay Announces Data Published in World Psychiatry on Deep Transcranial Magnetic Stimulation (Deep TMS™) for Smoking Addiction
08:00am, Thursday, 30'th Sep 2021
Evidence Supports Use of Deep TMS as a Safe and Effective Treatment for Smoking Addiction
BrainsWay to Participate in Two Upcoming Investor Conferences
08:00am, Thursday, 09'th Sep 2021
BURLINGTON, Mass. and JERUSALEM, Sept. 09, 2021 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulatio
BrainsWay to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
08:00am, Monday, 30'th Aug 2021
BURLINGTON, Mass. and JERUSALEM, Aug. 30, 2021 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation
BrainsWay Stock Gains On FDA Expanded Use Approval For Its Stimulation Device
08:03am, Wednesday, 18'th Aug 2021
The FDA has cleared BrainsWay Ltd's (NASDAQ:BWAY) Deep Transcranial Magnetic Stimulation (Deep TMS) System to reduce comorbid anxiety symptoms in adult patients with depression, also known as anxio
FDA Clears BrainsWay Deep TMS™ System for Decreasing Anxiety Symptoms in Depressed Patients
07:30am, Wednesday, 18'th Aug 2021
Expanded Depression Indication Further Demonstrates Company's Leadership Position Expanded Depression Indication Further Demonstrates Company's Leadership Position
BrainsWay Hosting Key Opinion Leader Webinar on its Deep TMS™ Therapy for Treating Mental Health Disorders
07:30am, Tuesday, 17'th Aug 2021
BURLINGTON, Mass. and JERUSALEM, Aug. 17, 2021 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation
BrainsWay Ltd.'s (BWAY) CEO Christopher von Jako on Q2 2021 Results - Earnings Call Transcript
12:54pm, Wednesday, 11'th Aug 2021
BrainsWay Ltd.'s (BWAY) CEO Christopher von Jako on Q2 2021 Results - Earnings Call Transcript
Engaging event for local mental health clinicians to learn more about BrainsWay's Deep Transcranial Magnetic Stimulation (Deep TMS) helmet, cleared to treat MDD and OCD, currently available in Charlot
BrainsWay to Present at Clinical TMS Society Annual Meeting and Psych Congress Elevate
08:01am, Monday, 07'th Jun 2021
CRESSKILL, N.J. and JERUSALEM, Israel, June 07, 2021 (GLOBE NEWSWIRE) -- BrainsWay Ltd . (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostim
BrainsWay (BWAY) is in Overbought Territory: What's Next?
07:31am, Thursday, 27'th May 2021
BrainsWay (BWAY) has moved higher as of late, but there could definitely be trouble on the horizon for this company
Brainsway Ltd. Sponsored ADR (BWAY) Moves 10.6% Higher: Will This Strength Last?
04:31am, Tuesday, 25'th May 2021
Brainsway Ltd. Sponsored ADR (BWAY) saw its shares surge in the last session with trading volume being higher than average.
BWAY Stock Price: Over 8% Increase Pre-Market Explanation
08:43am, Monday, 24'th May 2021
The stock price of Brainsway (NASDAQ: BWAY) increased by over 8% pre-market. This is why it happened.
